GabriellaD'AndreaMD

PubMed

• 27 citations
  Phase II Study of Paclitaxel and Dasatinib in Metastatic Breast Cancer.
  Patrick G. Morris, Selene Rota, Karen Cadoo, Stephen Zamora, Sujata Patil, Gabriella D'Andrea, Theresa Gilewski, Jacqueline Bromberg, Chau T. Dang, Maura N. Dickler, S...> ;Clinical Breast Cancer. 2018 Oct 1
• Hidden estrogen production from ovarian remnants leading to progression of disease in metastatic breast cancer.
  Ashley Weiner, Gabriella D'Andrea> ;The Breast Journal. 2018 Jan 22
• 30 citations
  Oncologist use and perception of large panel next-generation tumor sequencing
  Alison M. Schram, Dalicia N. Reales, Jesse Galle, Roy Cambria, Robert Durany, Darren R. Feldman, Eric J. Sherman, Jonathan E. Rosenberg, Gabriella D'Andrea, Shrujal S....> ;Annals of Oncology. 2017 Sep 1
• 52 citations
  A phase I trial of ganetespib in combination with paclitaxel and trastuzumab in patients with human epidermal growth factor receptor-2 (HER2)-positive metastatic breas...
  Komal Jhaveri, Rui Wang, Eleonora Teplinsky, Sarat Chandarlapaty, David B. Solit, Karen Cadoo, James L. Speyer, Gabriella D'Andrea, Sylvia Adams, Sujata Patil, Sofia H...> ;Breast Cancer Research. 2017 Aug 2
• 1 citations
  A Pilot Study of Dose-Dense Paclitaxel With Trastuzumab and Lapatinib for Node-negative HER2-Overexpressed Breast Cancer
  Neil M. Iyengar, Monica Fornier, Steven Sugarman, Maria Theodoulou, Tiffany A. Troso-Sandoval, Gabriella D'Andrea, Pamela Drullinsky, Devika Gajria, Shari Goldfarb, El...> ;Clinical Breast Cancer. 2016 Apr 1
• 57 citations
  Phase II Study of Paclitaxel Given Once per Week Along With Trastuzumab and Pertuzumab in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Br...
  Chau T. Dang, Neil M. Iyengar, FM Datko, Gabriella D'Andrea, Maria Theodoulou, Maura N. Dickler, Shari Goldfarb, Diana Lake, Julie Fasano, Monica Fornier, Theresa Gile...> ;Journal of Clinical Oncology. 2015 Feb 10
• 85 citations
  A phase II open-label study of ganetespib, a novel heat shock protein 90 inhibitor for patients with metastatic breast cancer.
  Komal Jhaveri, Sarat Chandarlapaty, Diana Lake, Teresa Gilewski, Mark E. Robson, Shari Goldfarb, Pamela Drullinsky, Steven Sugarman, Carolyn Wasserheit-Leiblich, Julie...> ;Clinical Breast Cancer. 2014 Jun 1
• 16 citations
  Phase II trial of a novel capecitabine dosing schedule in combination with lapatinib for the treatment of patients with HER2-positive metastatic breast cancer
  Devika Gajria, Joseph Gonzalez, Kimberly Feigin, Sujata Patil, Carol L. Chen, Maria Theodoulou, Pamela Drullinsky, Gabriella D'Andrea, Diana Lake, Larry Norton, Cliffo...> ;Breast Cancer Research and Treatment. 2012 Jan 1
• 44 citations
  A phase I study of dasatinib and weekly paclitaxel for metastatic breast cancer
  Monica Fornier, Patrick G. Morris, A. Abbruzzi, Gabriella D'Andrea, Teresa Gilewski, Jacqueline Bromberg, Chau T. Dang, Maura N. Dickler, Shanu Modi, Andrew D. Seidman...> ;Annals of Oncology. 2011 Dec 1
• 308 citations
  HSP90 Inhibition Is Effective in Breast Cancer: A Phase II Trial of Tanespimycin (17-AAG) Plus Trastuzumab in Patients with HER2-Positive Metastatic Breast Cancer Prog...
  Shanu Modi, Alison Stopeck, Hannah M. Linden, David B. Solit, Sarat Chandarlapaty, Neal Rosen, Gabriella D'Andrea, Maura N. Dickler, Mary Ellen Moynahan, Steven Sugarm...> ;Clinical Cancer Research. 2011 Aug 1
• TBCRC 011: Targeting the androgen receptor (AR) for the treatment of AR+/ER-/PR- metastatic breast cancer (MBC).
  Gucalp A, Tolaney SM, Isakoff SJ, Ingle JN, Liu MC, Carey LA, Blackwell KL, Rugo HS, Nabell L, Abbruzzi A, Gonzalez J, Giri DD, Patil S, Feigin K, D'Andrea G, Theodoul...> ;J. Clin. Oncol.. 2011-05-20
• 25 citations
  A Feasibility Study of Bevacizumab plus Dose-Dense Doxorubicin–Cyclophosphamide (AC) Followed by Nanoparticle Albumin–Bound Paclitaxel in Early-Stage Breast Cancer
  Heather L. McArthur, Hope S. Rugo, B. Nulsen, Laura Hawks, Jill Grothusen, Michelle E. Melisko, Mark M. Moasser, Matthew Paulson, Tiffany A. Traina, Sujata Patil, Qin ...> ;Clinical Cancer Research. 2011 May 15
• 4 citations
  Dose Dense Cyclophosphamide, Methotrexate, Fluorouracil is Feasible at 14-Day Intervals: A Pilot Study of Every-14-Day Dosing as Adjuvant Therapy for Breast Cancer
  Pamela Drullinsky, Steven Sugarman, Monica Fornier, Gabriella D'Andrea, Teresa Gilewski, Diana Lake, Tiffany A. Traina, Carolyn Wasserheit-Lieblich, Nancy Sklarin, Dee...> ;Clinical Breast Cancer. 2010 Dec 1
• Perfusion CT in solid body-tumours. Part II: Clinical applications and future development.
  Bellomi M, Viotti S, Preda L, D'Andrea G, Bonello L, Petralia G> ;Radiol Med. 2010-09-01
• CT perfusion in solid-body tumours. Part I: Technical issues.
  Petralia G, Preda L, D'Andrea G, Viotti S, Bonello L, De Filippi R, Bellomi M> ;Radiol Med. 2010-09-01
• 58 citations
  Phase II trial of weekly nanoparticle albumin-bound paclitaxel with carboplatin and trastuzumab as first-line therapy for women with HER2-overexpressing metastatic bre...
  Alison Conlin, Andrew D. Seidman, Ariadne M. Bach, Diana Lake, Maura N. Dickler, Gabriella D'Andrea, Tiffany A. Traina, Michael A. Danso, Adam Brufsky, Mansoor N. Sale...> ;Clinical Breast Cancer. 2010 Aug 1
• CT perfusion in oncology: how to do it.
  Petralia G, Bonello L, Viotti S, Preda L, d'Andrea G, Bellomi M> ;Cancer Imaging. 2010-02-11
• 13 citations
  A pilot study of dose-dense adjuvant paclitaxel without growth factor support for women with early breast carcinoma.
  Steven Sugarman, Carolyn Wasserheit, Elizabeth Hodgman, Maryellen Coglianese, Anne D’Alassandro, Monica Fornier, Tiffany A. Troso-Sandoval, Gabriella D'Andrea, Pamela ...> ;Breast Cancer Research and Treatment. 2009 Jul 22
• Intra- and interobserver agreement and impact of arterial input selection in perfusion CT measurements performed in squamous cell carcinoma of the upper aerodigestive ...
  Petralia G, Preda L, Raimondi S, D'Andrea G, Summers P, Giugliano G, Chiesa F, Bellomi M> ;AJNR Am J Neuroradiol. 2009-06-01
• Role of perfusion computed tomography (CTp) for pretherapy assessment and induction chemotherapy monitoring (IC) in patients with squamous cell carcinoma (SCC) of the ...
  Petralia G, Preda L, Chiesa F, Nolè F, d'Andrea G, Giugliano G, Verri E, Cossu Rocca M, Bellomi M> ;J. Clin. Oncol.. 2009-05-20
• Dose-dense (DD) cyclophosphamide, methotrexate, and fluorouracil (CMF) at 14-day intervals: A pilot study of every 14- and 10-11-day dosing intervals for women with ea...
  Drullinsky P, Fornier MN, Sugarman S, D'Andrea G, Troso-Sandoval T, Seidman AD, Yuan J, Patil S, Norton L, Hudis C> ;J. Clin. Oncol.. 2009-05-20
• 94 citations
  A phase I/II trial of a polysaccharide extract from Grifola frondosa (Maitake mushroom) in breast cancer patients: immunological effects
  Gary Deng, Hong Lin, Andrew D. Seidman, Monica Fornier, Gabriella D'Andrea, Kathleen M. Wesa, Simon Yeung, Susanna Cunningham-Rundles, Andrew J. Vickers, Barrie R. Cas...> ;Journal of Cancer Research and Clinical Oncology. 2009 Mar 1
• 89 citations
  A Phase II Trial of Erlotinib in Combination with Bevacizumab in Patients with Metastatic Breast Cancer
  Maura N. Dickler, Hope S. Rugo, Carey A. Eberle, Edi Brogi, James F. Caravelli, Katherine S. Panageas, Jeff Boyd, Benjamin M. Yeh, Diana Lake, Chau T. Dang, Teresa Gil...> ;Clinical Cancer Research. 2008 Dec 1
• 11 citations
  Prolonged Dose-Dense Epirubicin and Cyclophosphamide Followed by Paclitaxel in Breast Cancer Is Feasible
  Chau T. Dang, Gabriella D'Andrea, Diana Lake, Steve Sugarman, Monica Fornier, Mary Ellen Moynahan, Theresa Gilewski, Arti Hurria, Nancy Mills, Tiffany A. Troso-Sandova...> ;Clinical Breast Cancer. 2008 Oct 1
• Phase II study of weekly nanoparticle albumin bound (nab)paclitaxel with carboplatin and trastuzumab as 1st-line therapy for HER2-positive metastatic breast cancer (MBC).
  Seidman AD, Conlin AK, Bach A, Brufsky AM, Saleh MN, Lake D, Dickler MN, D'Andrea G, Traina TA, Hudis CA> ;J. Clin. Oncol.. 2008-05-20
• Join now to see all